{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:28:30Z","timestamp":1787610510290,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.urology.2018.02.033","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T03:09:22Z","timestamp":1520305762000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study"],"prefix":"10.1016","volume":"116","author":[{"given":"Juliette","family":"Hascoet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Forin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilien","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Capon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Prudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Allenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourdia","family":"Bouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Peycelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Renaux-Petel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Liard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Manunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Game","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.02.033_bib0010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(04)17445-X","article-title":"Spina bifida","volume":"364","author":"Mitchell","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.urology.2018.02.033_bib0015","first-page":"352","article-title":"Vesicosphincteric and sexual disorders associated with spina bifida and myelomeningocele","volume":"17","author":"Gam\u00e9","year":"2007","journal-title":"Progres En Urol J Assoc Fr Urol Soc Fr Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048399","article-title":"Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review","volume":"7","author":"Veenboer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urology.2018.02.033_bib0025","author":"Panek"},{"issue":"3 pt 1","key":"10.1016\/j.urology.2018.02.033_bib0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.juro.2015.03.107","article-title":"Update on urological management of spina bifida from prenatal diagnosis to adulthood","volume":"194","author":"Snow-Lisy","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ddrr.92","article-title":"Urologic management of spina bifida","volume":"16","author":"Clayton","year":"2010","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.urology.2018.02.033_bib0045","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0050","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0055","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.urology.2015.12.049","article-title":"Use of botulinum toxin in urologic diseases","volume":"91","author":"Chermansky","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urology.2018.02.033_bib0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/nau.23025","article-title":"Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: a systematic review","volume":"36","author":"Hascoet","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.02.033_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s002340000325","article-title":"Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification","volume":"42","author":"Tortori-Donati","year":"2000","journal-title":"Neuroradiology"},{"key":"10.1016\/j.urology.2018.02.033_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.urology.2018.02.033_bib0080","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/nau.22783","article-title":"International Children's Continence Society standardization report on urodynamic studies of the lower urinary tract in children","volume":"34","author":"Bauer","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.02.033_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/nau.22712","article-title":"Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity","volume":"35","author":"Peyronnet","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.02.033_bib0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00345-015-1666-5","article-title":"Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750\u2009U for treating neurological detrusor overactivity","volume":"34","author":"Peyronnet","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpurol.2014.08.009","article-title":"Botulinum injection is useless on fibrotic neuropathic bladders","volume":"11","author":"Tiryaki","year":"2015","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0105","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/nau.21124","article-title":"Repeated botulinum-a toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele","volume":"30","author":"Horst","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.02.033_bib0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1464-410X.2008.07606.x","article-title":"Microarray analysis of bladder smooth muscle from patients with myelomeningocele","volume":"102","author":"Hipp","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.02.033_bib0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/nau.23291","article-title":"Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed","volume":"37","author":"Bottet","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.02.033_bib0120","first-page":"145","article-title":"Management options for sphincteric deficiency in adults with neurogenic bladder","volume":"5","author":"Myers","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0125","article-title":"Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity","author":"Joussain","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.02.033_bib0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpurol.2014.09.009","article-title":"Mental health and parenting characteristics of caregivers of children with spina bifida","volume":"11","author":"Malm-Buatsi","year":"2015","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2018.02.033_bib0135","first-page":"910","article-title":"Testing the utility of a bio-neuropsychosocial model for predicting medical adherence and responsibility during early adolescence in youth with spina bifida","volume":"42","author":"Psihogios","year":"2016","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.urology.2018.02.033_bib0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/bju.13795","article-title":"Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivity","volume":"119","author":"Denys","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.02.033_bib0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ucl.2017.04.012","article-title":"Disease-specific outcomes of botulinum toxin injections for neurogenic detrusor overactivity","volume":"44","author":"Kaviani","year":"2017","journal-title":"Urol Clin North Am"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518301912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518301912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:34:47Z","timestamp":1556498087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518301912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":28,"alternative-id":["S0090429518301912"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.02.033","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732820664.793563770","asserted-by":"object"}]},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}